Journals / Retina-Vitreus / 2017 / Cilt: 26 - Sayı: 0

Bilateral Retinal Vein Occlusions In Primary Antiphospholipid Syndrome

Primer Antifosfolipid Sendromlu Olguda Bilateral Retinal Ven Okluzyonu

Pages
283–286
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

He underwent severalsurgical interventions, and resulted in legal blindness in one eye.Ocular manifestations of primary antiphospholipid syndrome isvariable, can be the first clinical sign, and result in legal blind-ness despite treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Our aim is to describe an atypical case of primary antiphospho-lipid syndrome with bilateral retinal vein occlusions.
📊
Key Findings & Data:A detailedclinical course with a 19-month follow-up is covered in the cur-rent case.
💡
Conclusion & Impact:He underwent severalsurgical interventions, and resulted in legal blindness in one eye.Ocular manifestations of primary antiphospholipid syndrome isvariable, can be the first clinical sign, and result in legal blind-ness despite treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Our aim is to describe an atypical case of primary antiphospho-lipid syndrome with bilateral retinal vein occlusions. A detailedclinical course with a 19-month follow-up is covered in the cur-rent case. The patient presented with retinal vein occlusion asa prevailing sign. He had hyperhomocysteinemia, methylene-tet-rahydrofolate-reductase enzyme (MTHFR) C677T mutation andlupus anticoagulant (LA) seropositivity. He underwent severalsurgical interventions, and resulted in legal blindness in one eye.Ocular manifestations of primary antiphospholipid syndrome isvariable, can be the first clinical sign, and result in legal blind-ness despite treatment.

Özet

Bu olguyu sunmadaki amacımız bilateral ven okluzyonu ile baş- vuran atipik bir primer antifosfolipid sendromu hastasını tanım- lamaktır. Hastamız 19 ay boyunca ayrıntılı şekilde takip edilmiş- tir. Hastanın başlangıç bulgusu bilateral retinal ven okluzyonu idi. Hastada hiperhomosisteinemi, metilen-tetrahidrafolat redük- taz enzimi (MTHFR) C677T mutasyonu ve lupus antikoagülan seropozitifl iği mevcuttu. Hastaya birçok cerrahi uygulanmasına karşın tek gözde yasal körlük ile sonuçlandı. Primer antifosfoli- pid sendromunun okuler özellikleri farklılık arzetmekte olup ilk bulgu göz rahatsızlığı olabileceği gibi yasal körlükle de sonuçla- nabilmektedir.

🔖

Cite This Article

AYYILDIZ, Ö., KÜÇÜKEVCİLİOĞLU, M., DURUKAN, A. H., GÜVEN, S. (2022). Bilateral Retinal Vein Occlusions In Primary Antiphospholipid Syndrome. Retina-Vitreus, Cilt: 26 - Sayı: 0, 283–286. https://ajindex.com/articles/589135

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Durrani, O.M., C. Gordon, P.I. Murray. Primary anti-phospholi- pid antibody syndrome (APS): current concepts. Surv Ophthal- mol, 2002. 47: 215-238.
  2. Asherson, R.A. A "primary" antiphospholipid syndrome? J Rheu- matol, 1988. 15: 1742-1746.
  3. Kleiner, R.C., Najarian LV, Schatten S et al. Vaso-occlusive reti- nopathy associated with antiphospholipid antibodies (lupus an- ticoagulant retinopathy). Ophthalmology, 1989. 96: 896-904.
  4. Chang, P.C., Chen WS, Lin HY et al. Combined central retinal artery and vein occlusion in a patient with systemic lupus ery- thematosus and anti-phospholipid syndrome. Lupus, 2010. 19: 206-209.
  5. Durukan, A.H., Akar Y, Bayraktar MZ et al. Combined retinal artery and vein occlusion in a patient with systemic lupus eryt- hematosus and antiphospholipid syndrome. Can J Ophthalmol, 2005. 40: 87-89.
  6. Glacet-Bernard, A., Bayani N, Chretien P et al. Antiphospholi- pid antibodies in retinal vascular occlusions. A prospective study of 75 patients. Arch Ophthalmol, 1994. 112: 790-795.
  7. Marcucci, R., Sodi A, Giambene B et al. Cardiovascular and th- rombophilic risk factors in patients with retinal artery occlusion. Blood Coagul Fibrinolysis, 2007. 18: 32 1-326.
  8. DeMarco, P., I. Singh, A. Weinstein. Management of the antip- hospholipid syndrome. Curr Rheumatol Rep, 2006. 8: 114-120.
  9. Etemadifar, M., Dehghani L, Tahani S et al. Neurological ma- nifestations in patients with antiphospholipid syndrome. Iran J Neurol, 2013. 12: 172-175.